Asian Journal of Pharmaceutical Research

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Orodispersible films of Ledipasvir and Sofosbuvir Combination: Formulation optimization and development using Design of Experiments


Affiliations
1 Associate Professor, Aditya College of Pharmacy, Surampalem, Kakinada, Andhra Pradesh, India Research Scholar, School of Pharmacy, JNT University Kakinada, Kakinada, Andhra Pradesh, India
2 Sir CR Reddy College of Pharmaceutical Sciences, Eluru, Andhra Pradesh, India
3 University College of Pharmaceutical Sciences, Acharya Nagarjuna University, Guntur, Andhra Pradesh, India
     

   Subscribe/Renew Journal


Ledipasvir (LDV) and sofosbuvir (SBV) are poorly soluble drugs and hence dissolution limited bioavailability is a major concern. Further, the high total dose of this combination (LDV-90mg and SBV-400mg) may cause swallowing difficulties if formulated into tablets. Considering these challenges, it was aimed in the current research work to develop orodispersible films (ODFs) for this combination to enhance dissolution thereby bioavailability and also patient convenience. ODFs, because of their ready dispersibility in the oral cavity dissolution would be rapid and also high doses of drugs can be incorporated avoiding swallowing difficulties. HPMC E15 was taken as the film former. Thickness of the films (50&#956m – 150&#956m), concentration of superdisintegrant (sodium starch glycolate 6-12% w/w) and concentration of plasticizer (polyethylene glycol 400, 10-20% w/w) were taken as three formulation factors each at three levels. Using Design Expert software, Box-Behnken design under response surface methodology was selected as the experimental design. Disintegration time (DT), time for 90% dissolution of LDV (LDV-T90%) and time for 90% dissolution of SBV (SBV-T90%) of the ODFs were taken as response. The films were developed using solvent casting method. The obtained films were subjected for various quality characteristic studies like differential scanning calorimetry, X- ray diffraction, tensile strength, % elongation, folding endurance, disintegration time, drug content uniformity and dissolution studies. All the formulations were found to have favorable tensile strength, % elongation and folding endurance. The DT values were found to be in the range of 37 – 139 sec.; the values of LDV-T90% and SBV-T90% were found to be in the range of 7.1 – 20.7 min. and 6.8 – 15.6 min. respectively. The results of these three responses were subjected to ANOVA studies and found that all the three formulation factors were having significant effect. The results of optimization by desirability functions approach indicated the ODFs with thickness 50μm, disintegrant at 12% w/w and plasticizer at 17.46%w/w as the optimized formulation. The ODFs prepared at this combination showed DT of 45 sec, LDV-T90% of 7.51 min. and SBV-T90% of 6.23 min. these results indicated that ODFs for LDV and SBV were successfully optimized and developed.


Keywords

Ledipasvir and Sofosbuvir, Orodispersible films, Dissolution enhancement, Box-Behnken design, Optimization
Subscription Login to verify subscription
User
Notifications
Font Size


  • Afdhal N et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. New England Journal of Medicine. 2014 May 15;370(20):1889-98. doi: 10.1056/NEJMoa1402454.

  • Rezaee-Zavareh MS et al. Combination of ledipasvir and sofosbuvir for treatment of hepatitis c virus genotype 1 infection: Systematic review and meta-analysis. Annals of Hepatology. 2017 Mar- Apr;16(2):188-97. doi: 10.5604/16652681.1231577.

  • German P. et al. Clinical pharmacokinetics and pharmacodynamics of ledipasvir/sofosbuvir, a fixed-dose combination tablet for the treatment of hepatitis C. Clinical Pharmacokinetics. 2016 May 18;55:1337-51. doi: 10.1007/s40262-016-0397-0

  • Rinaki E et al. Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio. Pharmaceutical Research. 2003 Dec;20(12):1917-25. doi: 10.1023/b:pham.0000008037.57884.11.

  • Mandake GR et al. Dissolution enhancement of Telmisartan by spray drying technique. Asian Journal of Pharmacy and Technology.2018 Oct-Dec;8(4):264-9. doi: 10.5958/2231-5713.2018.00040.5

  • Bhagat BV, Darkunde S. Orodispersible Film: A novel drug delivery system. Research Journal of Pharmacy and Technology. 2014 Oct;7(10):1196-1200.

  • Srikar G et al. Formulation optimization and characterization of amlodipine oral disintegrating tablets prepared by co-grinding technique. Der Pharmacia Lettre. 2013;5(4):335-43.

  • Khan QU et al. Development and characterization of orodispersible film containing cefixime trihydrate. Drug Development and Industrial Pharmarmacy. 2020 Dec;46(12):2070-2080. doi: 10.1080/03639045.2020.1843477.

  • Ahmad A et al. Development and Evaluation of Orodispersible Films by Solvent Casting Method Using Eletriptan Hydrobromide as a Model Drug. Latin American Journal of Pharmacy. 2020; 39(10): 1951-6.

  • Varsha A et al. Formulation development and evaluation of fast dissolving films of oloptadine HCl. Asian Journal of Research in Pharmaceutical Sciences. 2021; 11(2):103-8. doi: 10.52711/2231- 5659.2021-11-2-2

  • Guntaka PCR, Lankapalli S. A comparative study of ledipasvir solid dispersion technique using spray drying and hot-melt extrusion. International Journal of Pharmaceutical Sciences and Research. 2018;9(12):5145-54.

  • SrikarG,RaniAP.Studyoninfluenceofpolymerandsurfactantonin vitro performance of biodegradable aqueous-core nanocapsules of tenofovir disoproxil fumarate by response surface methodology. Brazilian Journal of Pharmaceutical Sciences. 2019;55:e18736. doi: 10.1590/s2175-97902019000118736.

  • Kolekar YM. Understanding of DoE and its advantages in Pharmaceutical development as per QbD Approach. Asian Journal of Pharmacy and Technology. 2019 Oct-Dec;9(4):271-5. doi: 10.5958/2231-5713.2019.00045.X

  • Srikar G, Rani AP. Tenofovir loaded poly (lactide-co-glycolide) nanocapsules: Formulation optimization by desirability functions approach. Indian Journal of Pharmaceutical Education and Research. 2020 Apr-Jun;54(2S):S230-S240. doi: 10.5530/ijper.54.2s.79.

  • Thummala UK et al. Estimation of ledipasvir and sofosbuvir by Vierdot’s method in bulk and dosage forms. International Journal of Pharmacy and Biological Sciences. 2018 Apr-Jun;8(2):35-42.

  • Rahmani S et al. Optimization of Drug loading in Modified Nano- zeolites using response surface methodology by Box–Behnken design. Asian Journal of Pharmaceutical Research. 2020 April – June;10(2):55- 61. doi: 10.5958/2231-5691.2020.00011.8

  • Kalbhare SB et al. Role of aminated derivatives of natural gum in release modulating matrix systems of losartan potassium: Optimization of formulation using Box-Behnken design. Asian Journal of Pharmaceutical Research. 2021 Apr-Jun; 11(2):73-4. doi: 10.52711/2231-5691.2021.00015

  • BansalS,GargG.DesignandOptimizationofFastDissolvingFilmof Losartan. Research Journal of Pharmacy and Technology. 2014 November; 7(11):1211-8.

  • Nirmala D et al. Design and evaluation of fast dissolving oral films of zolpidem by solvent casting method. Asian Journal of Pharmaceutical Research. 2016;6(2):67-71. doi: 10.5958/2231-5691.2016.00012.5.

  • Pushkarna N et al. Binary Solid Dispersions of Telmisartan using natural modified Neem Gum: Development and Characterization. Research Journal of Pharmacy and Technology. 2019; 12(9):4387-93. doi:10.5958/0974-360X.2019.00754.6.

  • Jayarao YR et al. Formulation and evaluation of fast dissolving oral films of perindopril. Research Journal of Pharmaceutical Dosage Forms and Technology. April- June 2014; 6(2):71-80.

  • Sanyang ML et al. Effect of plasticizer type and concentration on physical properties of biodegradable films based on sugar palm (Arenga pinnata) starch for food packaging. Journal of Food Science and Technology. 2016 Jan;53(1):326–36. doi:10.1007/s13197-015- 2009-7.

  • Zhang L et al. Impact of super-disintegrants and film thickness on disintegration time of strip films loaded with poorly water soluble drug microparticles. Journal of Pharmaceutical Science. 2018 Aug; 107(8): 2107-18. doi:10.1016/j.xphs.2018.04.006.

  • Swamy SK et al. Effect of Various Super Disintegrants on the Drug Release Profile of Orally Disintegrating Tablets. Asian Journal of Pharmacy and Technology. 2016; 6(2): 99-105. doi:10.5958/2231- 5713.2016.00014.3.

  • Roy A et al. Effects of plasticizers and surfactants on the film forming properties of hydroxypropyl methylcellulose for the coating of diclofenac sodium tablets. Saudi Pharmaceutical Journal. 2009;17:233- 41doi:10.1016/j.jsps.2009.08.004.

  • Vieira MGA et al. Natural-based plasticizers and biopolymer films: A review. European Polymer Journal. 2011; 47: 254–63. doi:10.1016/j.eurpolymj.2010.12.011.


Abstract Views: 126

PDF Views: 0




  • Orodispersible films of Ledipasvir and Sofosbuvir Combination: Formulation optimization and development using Design of Experiments

Abstract Views: 126  |  PDF Views: 0

Authors

Uday Kumar Thummala
Associate Professor, Aditya College of Pharmacy, Surampalem, Kakinada, Andhra Pradesh, India Research Scholar, School of Pharmacy, JNT University Kakinada, Kakinada, Andhra Pradesh, India
Eswar Guptha Maddi
Sir CR Reddy College of Pharmaceutical Sciences, Eluru, Andhra Pradesh, India
Prameela Rani Avula
University College of Pharmaceutical Sciences, Acharya Nagarjuna University, Guntur, Andhra Pradesh, India

Abstract


Ledipasvir (LDV) and sofosbuvir (SBV) are poorly soluble drugs and hence dissolution limited bioavailability is a major concern. Further, the high total dose of this combination (LDV-90mg and SBV-400mg) may cause swallowing difficulties if formulated into tablets. Considering these challenges, it was aimed in the current research work to develop orodispersible films (ODFs) for this combination to enhance dissolution thereby bioavailability and also patient convenience. ODFs, because of their ready dispersibility in the oral cavity dissolution would be rapid and also high doses of drugs can be incorporated avoiding swallowing difficulties. HPMC E15 was taken as the film former. Thickness of the films (50&#956m – 150&#956m), concentration of superdisintegrant (sodium starch glycolate 6-12% w/w) and concentration of plasticizer (polyethylene glycol 400, 10-20% w/w) were taken as three formulation factors each at three levels. Using Design Expert software, Box-Behnken design under response surface methodology was selected as the experimental design. Disintegration time (DT), time for 90% dissolution of LDV (LDV-T90%) and time for 90% dissolution of SBV (SBV-T90%) of the ODFs were taken as response. The films were developed using solvent casting method. The obtained films were subjected for various quality characteristic studies like differential scanning calorimetry, X- ray diffraction, tensile strength, % elongation, folding endurance, disintegration time, drug content uniformity and dissolution studies. All the formulations were found to have favorable tensile strength, % elongation and folding endurance. The DT values were found to be in the range of 37 – 139 sec.; the values of LDV-T90% and SBV-T90% were found to be in the range of 7.1 – 20.7 min. and 6.8 – 15.6 min. respectively. The results of these three responses were subjected to ANOVA studies and found that all the three formulation factors were having significant effect. The results of optimization by desirability functions approach indicated the ODFs with thickness 50μm, disintegrant at 12% w/w and plasticizer at 17.46%w/w as the optimized formulation. The ODFs prepared at this combination showed DT of 45 sec, LDV-T90% of 7.51 min. and SBV-T90% of 6.23 min. these results indicated that ODFs for LDV and SBV were successfully optimized and developed.


Keywords


Ledipasvir and Sofosbuvir, Orodispersible films, Dissolution enhancement, Box-Behnken design, Optimization

References